KLK12
Kallikrein-related peptidase 11 (KLK11) is a member of the kallikrein subfamily of serine proteases, which are enzymes that cleave peptide bonds in proteins. KLK11 is encoded by the KLK11 gene located on chromosome 19q13.3-13.4, a region that contains a cluster of 15 kallikrein genes.
Structure
The KLK11 gene is composed of 7 exons and encodes a preproprotein that is processed to generate the mature enzyme. The mature KLK11 protein consists of 250 amino acids and has a molecular weight of approximately 28 kDa. Like other kallikreins, KLK11 contains a catalytic triad composed of histidine, aspartate, and serine residues, which are essential for its proteolytic activity.
Function
KLK11 is involved in various physiological processes, including skin desquamation, semen liquefaction, and neural plasticity. It is expressed in a wide range of tissues, with particularly high levels in the prostate, brain, and skin. In the prostate, KLK11 is thought to play a role in semen liquefaction by cleaving semenogelins, which are proteins that form the gel matrix of semen.
Clinical Significance
KLK11 has been studied as a potential biomarker for prostate cancer and other malignancies. Elevated levels of KLK11 have been detected in the serum of patients with prostate cancer, suggesting its potential use in cancer diagnosis and monitoring. Additionally, KLK11 expression has been observed in ovarian, breast, and other cancers, indicating its broader relevance in oncology.
Regulation
The expression of KLK11 is regulated by steroid hormones, including androgens and estrogens. This regulation is mediated through hormone response elements in the promoter region of the KLK11 gene. The precise mechanisms of KLK11 regulation and its interaction with other kallikreins remain active areas of research.
Research Directions
Ongoing research is focused on understanding the role of KLK11 in cancer progression and its potential as a therapeutic target. Studies are also exploring the enzyme's function in the central nervous system and its involvement in neurodegenerative diseases.
Also see
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD